Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Mar 2022	78	Global Markets Direct	ASDR-599120

Published: Mar 2022 - Pages : 78 - Publisher : Global Markets Direct - Report code : ASDR-599120

Feldan Therapeutics Inc
Genentech USA Inc
Kintara Therapeutics Inc
Mayne Pharma Group Ltd
Ono Pharmaceutical Co Ltd
Palvella Therapeutics LLC
PellePharm Inc

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2020

This report can be of interest as well:

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2020

Published: October, 2020 | Report code: ASDR-567847